The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
ctDNA as a noninvasive monitoring tool in metastatic melanoma.
 
Renata Varaljai
No Relationships to Disclose
 
Kilian Wistuba-Hamprecht
No Relationships to Disclose
 
Teofila Seremet
Employment - GlaxoSmithKline (I); Janssen (I)
Honoraria - Janssen; Novartis
Consulting or Advisory Role - Novartis
Speakers' Bureau - Novartis
Travel, Accommodations, Expenses - Janssen; LEO Pharma; MSD Oncology; Novartis
 
Joey Mark Santiago Diaz
No Relationships to Disclose
 
Jeremie Nsengimana
No Relationships to Disclose
 
Antje Sucker
No Relationships to Disclose
 
Klaus Griewank
Patents, Royalties, Other Intellectual Property - Exon 4 mutations in GNAQ and GNA11 A rare gene mutation in melanoma, I receive annual payments (around 100 dollars 2016)
Travel, Accommodations, Expenses - Roche
 
Peter Horn
Stock and Other Ownership Interests - owning share certificates (Aktien) of different companies; owning share certificates (Aktien) of different companies
Patents, Royalties, Other Intellectual Property - Patent applications as descibed below
 
Nils von Neuhoff
No Relationships to Disclose
 
Batool Shannan
No Relationships to Disclose
 
Heike Chauvistré
No Relationships to Disclose
 
Felix Christian Eduard Vogel
No Relationships to Disclose
 
Susanne Horn
No Relationships to Disclose
 
Jürgen C. Becker
Consulting or Advisory Role - Amgen; Etherna; Merck Serono; Sanofi/Regeneron (I)
Speakers' Bureau - Alcedis; Amgen; Bristol-Myers Squibb; IQVIA; Merck Serono; Merck Serono; Novartis; Sanofi/Regeneron
Travel, Accommodations, Expenses - 4SC; Merck Serono
 
Julia Newton-Bishop
Travel, Accommodations, Expenses - Unknown mixed
 
Andreas Stang
No Relationships to Disclose
 
Bart Neyns
Honoraria - Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis; Roche
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Etherna; Merck Sharp & Dohme; Novartis; Pfizer/EMD Serono; Roche; Sanofi
Speakers' Bureau - Novartis
Research Funding - Merck KGaA (Inst); Novartis (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis; Roche
 
Benjamin Weide
Honoraria - Bristol-Myers Squibb; MSD; Roche
Consulting or Advisory Role - CureVac; Philogen
Research Funding - Bristol-Myers Squibb (Inst); MSD (Inst); Philogen (Inst)
 
Dirk Schadendorf
Honoraria - 4SC; Agenus; Amgen; Array BioPharma; AstraZeneca; Bristol-Myers Squibb; Grunenthal; Immunocore; Incyte; LEO Pharma; Merck Serono; Merck Sharp & Dohme; Mologen; Novartis; Pfizer; Philogen; Pierre Fabre; Regeneron; Roche/Genentech; Sysmex
Consulting or Advisory Role - 4SC; Amgen; Bristol-Myers Squibb; Immunocore; Incyte; Merck Serono; Merck Sharp & Dohme; Mologen; Novartis; Pierre Fabre; Roche/Genentech; Sanofi/Regeneron
Speakers' Bureau - Amgen; Bristol-Myers Squibb; Incyte; Merck Sharp & Dohme; Novartis; Pierre Fabre; Roche
Research Funding - Bristol-Myers Squibb (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Merck; Merck Serono; Novartis; Roche/Genentech
 
Alexander Roesch
Honoraria - Novartis
Consulting or Advisory Role - Novartis
Research Funding - Adtec (Inst); Bristol-Myers Squibb (Inst); Novartis (Inst)